Program
#AHA24
Late-Breaking Science
Daily Coverage
Industry Highlights
Photo Gallery
Journeys
Nov 1st, 2022
Watch: Scientific Session Virtual Platform tour
Start exploring today.
More Content
AHA22
Early ablation bests medication in treatment naïve AFib patients
AHA22
First-in-class aminopeptidase-A inhibitor fails to reduce treatment-resistant hypertension
AHA22
#AHA 22 Closing Session: That’s a wrap
AHA22
Congratulations to the winners of the Wellness Challenge and Scavenger Hunt
AHA22
Special Recognition to the Hinsdale Humane Society
AHA22
Trial results shed light on tool for assessing VTE risk, routine anticoagulation for non-hospitalized COVID patients, and clinical outcomes of open vs. endovascular surgery for advanced PAD
AHA22
Trials’ results highlight supplement ineffectiveness and potential for novel therapies to lower lipoprotein(a), reduce CKD progression
AHA22
Medtech is getting smarter — and so is patient care
AHA22
New digital hub offers professional education to complement lifelong learning
AHA22
Uncovering novel approaches in heart failure science
AHA22
Trial results report on benefits of radial artery for CABG, use of prophylactic methylprednisolone and ECMO for patients in cardiogenic shock
AHA22
Science, medicine must be a ‘relentless force’ in fighting misinformation